Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Drug interactions between ribociclib and Vayarin

Results for the following 2 drugs:
ribociclib
Vayarin (omega-3 polyunsaturated fatty acids)

Interactions between your drugs

There were no interactions found in our database between ribociclib and Vayarin - however, this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

ribociclib

A total of 795 drugs are known to interact with ribociclib.

Vayarin

A total of 126 drugs are known to interact with Vayarin.

Drug and food interactions

Moderate

ribociclib food

Applies to: ribociclib

Patients should not consume pomegranates, pomegranate juice, grapefruit, or grapefruit juice during treatment with ribociclib unless directed otherwise by your doctor. Pomegranate juice or grapefruit juice can increase the blood levels of ribociclib. You may be more likely to experience side effects such as nausea; vomiting; diarrhea; loss of appetite; abdominal pain; mouth sores; hair loss; weakness; and impaired bone marrow function resulting in low numbers of different types of blood cells, which can increase the risk of anemia, bleeding problems, and infections. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Switch to professional interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide